NRXP
Price
$3.38
Change
+$0.06 (+1.81%)
Updated
Jul 3 closing price
Capitalization
65.92M
TVRD
Price
$22.46
Change
+$1.01 (+4.71%)
Updated
Jul 3 closing price
Capitalization
210.25M
Interact to see
Advertisement

NRXP vs TVRD

Header iconNRXP vs TVRD Comparison
Open Charts NRXP vs TVRDBanner chart's image
NRX Pharmaceuticals
Price$3.38
Change+$0.06 (+1.81%)
Volume$93.87K
Capitalization65.92M
Tvardi Therapeutics
Price$22.46
Change+$1.01 (+4.71%)
Volume$19.66K
Capitalization210.25M
NRXP vs TVRD Comparison Chart in %
Loading...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRXP vs. TVRD commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRXP is a StrongBuy and TVRD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (NRXP: $3.38 vs. TVRD: $22.46)
Brand notoriety: NRXP and TVRD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRXP: 30% vs. TVRD: 28%
Market capitalization -- NRXP: $65.92M vs. TVRD: $210.25M
NRXP [@Biotechnology] is valued at $65.92M. TVRD’s [@Biotechnology] market capitalization is $210.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRXP’s FA Score shows that 0 FA rating(s) are green whileTVRD’s FA Score has 1 green FA rating(s).

  • NRXP’s FA Score: 0 green, 5 red.
  • TVRD’s FA Score: 1 green, 4 red.
According to our system of comparison, TVRD is a better buy in the long-term than NRXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRXP’s TA Score shows that 3 TA indicator(s) are bullish while TVRD’s TA Score has 3 bullish TA indicator(s).

  • NRXP’s TA Score: 3 bullish, 5 bearish.
  • TVRD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both NRXP and TVRD are a bad buy in the short-term.

Price Growth

NRXP (@Biotechnology) experienced а -3.43% price change this week, while TVRD (@Biotechnology) price change was -10.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

NRXP is expected to report earnings on May 15, 2025.

TVRD is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TVRD($210M) has a higher market cap than NRXP($65.9M). TVRD YTD gains are higher at: 266.993 vs. NRXP (53.636). TVRD has more cash in the bank: 34.2M vs. NRXP (5.55M).
NRXPTVRDNRXP / TVRD
Capitalization65.9M210M31%
EBITDA-24.11MN/A-
Gain YTD53.636266.99320%
P/E Ratio0.36N/A-
Revenue0N/A-
Total Cash5.55M34.2M16%
Total Debt8.4MN/A-
FUNDAMENTALS RATINGS
NRXP vs TVRD: Fundamental Ratings
NRXP
TVRD
OUTLOOK RATING
1..100
6658
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3734
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TVRD's Valuation (5) in the null industry is somewhat better than the same rating for NRXP (57). This means that TVRD’s stock grew somewhat faster than NRXP’s over the last 12 months.

TVRD's Profit vs Risk Rating (100) in the null industry is in the same range as NRXP (100). This means that TVRD’s stock grew similarly to NRXP’s over the last 12 months.

TVRD's SMR Rating (100) in the null industry is in the same range as NRXP (100). This means that TVRD’s stock grew similarly to NRXP’s over the last 12 months.

TVRD's Price Growth Rating (34) in the null industry is in the same range as NRXP (37). This means that TVRD’s stock grew similarly to NRXP’s over the last 12 months.

NRXP's P/E Growth Rating (94) in the null industry is in the same range as TVRD (100). This means that NRXP’s stock grew similarly to TVRD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NRXPTVRD
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLRT0.02N/A
+3.12%
Metalert Inc
FPRUY37.25N/A
N/A
Fraport AG
NBVAF0.08N/A
N/A
Nubeva Technologies Ltd.
NPACY1.25N/A
N/A
Quadient SA
HXGBY9.92-0.17
-1.68%
Hexagon AB

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with RNAC. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
+1.81%
RNAC - NRXP
86%
Closely correlated
-1.41%
NCNA - NRXP
85%
Closely correlated
-5.13%
TAOX - NRXP
84%
Closely correlated
+5.20%
AGEN - NRXP
83%
Closely correlated
+10.16%
ALLR - NRXP
81%
Closely correlated
+1.00%
More

TVRD and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVRD has been loosely correlated with APM. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TVRD jumps, then APM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVRD
1D Price
Change %
TVRD100%
+4.71%
APM - TVRD
41%
Loosely correlated
+4.18%
COEP - TVRD
38%
Loosely correlated
+0.80%
VSTM - TVRD
33%
Loosely correlated
-1.03%
NRXP - TVRD
28%
Poorly correlated
+1.81%
ACAD - TVRD
22%
Poorly correlated
-1.37%
More